Zhu Y - Search Results

1

Diagnosis and treatment of hepatic tuberculosis: report of five cases and review of literature.

Wu Z, Wang WL, Zhu Y, Cheng JW, Dong J, Li MX, Yu L, Lv Y, Wang B. Wu Z, et al. Among authors: zhu y. Int J Clin Exp Med. 2013 Sep 25;6(9):845-50. eCollection 2013. Int J Clin Exp Med. 2013. PMID: 24179582 Free PMC article.

2

Ischemic preconditioning versus intermittent clamping of portal triad in liver resection: A meta-analysis of randomized controlled trials.

Zhu Y, Dong J, Wang WL, Li MX, Long ZD, Zhen XL, Lv Y. Zhu Y, et al. Hepatol Res. 2014 Aug;44(8):878-87. doi: 10.1111/hepr.12193. Epub 2013 Aug 15. Hepatol Res. 2014. PMID: 23819558

3

Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.

Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L, Lv Y. Li MX, et al. Among authors: zhu y. Int J Cancer. 2014 May 15;134(10):2403-13. doi: 10.1002/ijc.28536. Epub 2014 Jan 29. Int J Cancer. 2014. PMID: 24122750 Review.

4

Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.

Wang WL, Zhu Y, Cheng JW, Li MX, Xia JM, Hao J, Yu L, Lv Y, Wu Z, Wang B. Wang WL, et al. Among authors: zhu y. Eur J Gastroenterol Hepatol. 2014 Apr;26(4):444-51. doi: 10.1097/MEG.0000000000000046. Eur J Gastroenterol Hepatol. 2014. PMID: 24463566

5

The value of the combination of fibrosis index based on the four factors and future liver remnant volume ratios as a predictor on posthepatectomy outcomes.

Dong J, Zhang XF, Zhu Y, Ma F, Liu C, Wang WL, Liu XM, Wang B, Lv Y. Dong J, et al. Among authors: zhu y. J Gastrointest Surg. 2015 Apr;19(4):682-91. doi: 10.1007/s11605-014-2727-6. Epub 2015 Jan 13. J Gastrointest Surg. 2015. PMID: 25583440

6

Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience.

Dong J, Zhu Y, Ma F, Ren Y, Lu J, Wang Z, Qin L, Wu R, Lv Y. Dong J, et al. Among authors: zhu y. Medicine (Baltimore). 2016 Aug;95(31):e4383. doi: 10.1097/MD.0000000000004383. Medicine (Baltimore). 2016. PMID: 27495049 Free PMC article.

7

A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.

Zhu Y, Xu D, Zhang Z, Dong J, Zhou Y, Zhang WW, Hong L, Zhu WW. Zhu Y, et al. Among authors: zhu ww. Int J Surg. 2018 Sep;57:45-53. doi: 10.1016/j.ijsu.2018.07.011. Epub 2018 Aug 1. Int J Surg. 2018. PMID: 30075291 Free article.

8

Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8⁺ T-cell immune responses.

Zhu Y, Wang XY, Zhang Y, Xu D, Dong J, Zhang Z, Yi CH, Jia HL, Yang X. Zhu Y, et al. Cancer Manag Res. 2018 Oct 2;10:4113-4123. doi: 10.2147/CMAR.S172719. eCollection 2018. Cancer Manag Res. 2018. PMID: 30323667 Free PMC article.

9

MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis.

Ke M, Zhang Z, Cong L, Zhao S, Li Y, Wang X, Lv Y, Zhu Y, Dong J. Ke M, et al. Among authors: zhu y. Biomed Pharmacother. 2019 Dec;120:109523. doi: 10.1016/j.biopha.2019.109523. Epub 2019 Oct 23. Biomed Pharmacother. 2019. PMID: 31655310 Free article.

10

The Combination Therapy of Fluorouracil and Oxaliplatin Suppress the Progression of Colon Cancer Through miR-183-5p/SOCS3 Axis and Downregulating PD-L1.

Tu C, Wang Y, Cheng X, Zhu Y, Yuan W, Dong J. Tu C, et al. Among authors: zhu y. Cancer Manag Res. 2021 Feb 25;13:1999-2008. doi: 10.2147/CMAR.S281925. eCollection 2021. Cancer Manag Res. 2021. PMID: 33658858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,324 results

Search Page

Filters